Skip to main content
. 2012 Feb 4;379(9814):432–444. doi: 10.1016/S0140-6736(11)61625-5

Figure 5.

Figure 5

Time to recurrence, breast cancer mortality, and overall mortality for chemotherapy versus no adjuvant chemotherapy

Left: four or more cycles of any anthracycline (Anth)-based regimen—eg, standard 4AC. Right: standard or near-standard CMF. RR (and its 95% CI)=event rate ratio, from summed log-rank statistics for all time periods combined. Gain (and its SE)=absolute difference between ends of graphs. CTX=chemotherapy. Event rates, %/year, are followed by (first events/woman-years). Error bars show ±1 SE.